Skip to main content
SpringerLink
Log in

Improving Outcome of Hodgkins Disease with Autologous Hematopoietic Stem Cell Transplantation

  • Original Article
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

We report analysis of all consecutive Hodgkins disease patients undergoing autologous hematopoietic stem cell transplant from September 1999 to December 2014. Out of total 38 patients 26 were males and 12 were females. 32 were adults and 6 were pediatric (<18 years). None were elderly. Median age was 28 years (9–61). All received BEAM protocol as conditioning regimen. Median engraftment time for granulocytes was 12 and 14 days for platelets. Thirty three (86.84 %) patients achieved complete remission out of which 8 (24.24 %) had further relapse. Transplant related mortality occurred in 4 (10 %) patients. Finally 26 (78.78 %) patients were disease free at median follow up of 60 months and median disease free survival (DFS) was 35 months. DFS was 66.66 and 65 %, respectively on 3 and 5 years. While overall survival was 70.83 and 70 % on 3 and 5  years, respectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Diehl V, Franklin J, Pfreundschuh M et al (2003) Standard and increased chemotherapy compared with COPP–ABVD for advanced Hodgkin’s disease. N Engl J Med 348:2386–2395

    Article  CAS  PubMed  Google Scholar 

  2. Longo D, Duffey P, Young R et al (1992) Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin’s disease after combination chemotherapy: the low probability for cure. J Clin Oncol 10:210–218

    CAS  PubMed  Google Scholar 

  3. Ljungman P, Bregni M, Brune M et al (2010) Allogenic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transpl 45:219–234

    Article  CAS  Google Scholar 

  4. Armitage JO (2010) Early-stage Hodgkin’s lymphoma. N Engl J Med 363(7):653–662

    Article  CAS  PubMed  Google Scholar 

  5. Kuruvilla J (2009) Standard therapy of advanced Hodgkin lymphoma. Hematol Am Soc Hematol Educ Program 2009:497–506

    Article  Google Scholar 

  6. Sureda A, Schouten HC (2012) HSCT for Hodgkin’s lymphoma in adults. In: Apperley J, Carreras E, Gluckman E, Masszi T (eds) Hematopoietic stem cell transplantation, 6th edn. Forum service editore, Paris, p 431

    Google Scholar 

  7. Linch DC, Winfield D, Goldstone AH et al (1993) Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin’s disease: results of a BNLI randomised trial. Lancet 341(8852):1051–1054

    Article  CAS  PubMed  Google Scholar 

  8. Schmitz N, Pfistner B, Sextro M et al (2002) Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous hematopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin’s disease: a randomised trial. Lancet 359(9323):2065–2071

    Article  CAS  PubMed  Google Scholar 

  9. Josting A, Muller H, Borchmann P et al (2010) Dose intensity of chemotherapy in patients with relapsed Hodgkin’s lymphoma. J Clin Oncol 28:5074–5080

    Article  PubMed  Google Scholar 

  10. Kumar L, Ganessan P, Ghosh I, Panda D, Gogia A, Mandhania S (2010) Autologous blood stem cell transplantation for Hodgkin and non-Hodgkin lymphoma: complications and outcome. Natl Med J India 23(6):330–335

  11. Chopra R, Macmillan AK, Linch DC et al (1993) The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor risk Hodgkin’s disease: a single center eight year study of 155 patients. Blood 81:1137–1145

    CAS  PubMed  Google Scholar 

  12. Sweetenham JW, Carella AM, Taghipour G et al (1999) High dose therapy and autologous stem cell transplantation for adult patients with Hodgkin’s disease who fail to enter remission after induction chemotherapy: results in 175 patients reported to the EBMT. J Clin Oncol 17:3101–3109

    CAS  PubMed  Google Scholar 

  13. Rapoport AP, Rowe JM, Dipersio JF (1991) High-dose chemotherapy followed by autologous stem cell rescue for refractory Hodgkin’s disease and non-Hodgkin’s lymphoma. In: Zander AR, Barlogie B (eds) Autologous bone marrow transplantation for Hodgkin’s diseases, non-Hodgkin’s lymphoma and multiple myeloma. Springer-Verlag, Berlin. http://www.science-connections.com/trends/human_leukemia/109.htm.htm

Download references

Author information

Authors and Affiliations

  1. GCRI, Ahmedabad, India

    Shreeniwas Raut, Sandip Shah, Kamalesh Shah, Kinnari Patel, Shailesh Talati, Sonia Parikh, Asha Anand, Harsha Panchal, Apurva Patel & Akhil Jain

Authors
  1. Shreeniwas Raut
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sandip Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kamalesh Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kinnari Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shailesh Talati
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sonia Parikh
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Asha Anand
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Harsha Panchal
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Apurva Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Akhil Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shreeniwas Raut.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Raut, S., Shah, S., Shah, K. et al. Improving Outcome of Hodgkins Disease with Autologous Hematopoietic Stem Cell Transplantation. Indian J Hematol Blood Transfus 32, 176–181 (2016). https://doi.org/10.1007/s12288-015-0559-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-015-0559-5

Keywords

Search

Navigation